Chen L - Search Results

1

Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma.

Du XJ, Wang GY, Zhu XD, Han YQ, Lei F, Shen LF, Yang KY, Chen L, Mao YP, Tang LL, Li L, Wu Z, Xu GQ, Zhou Q, Huang J, Guo R, Zhang Y, Liu X, Zhou GQ, Li WF, Xu C, Lin L, Chen YP, Chen FP, Liang XY, Chen SY, Li SQ, Cui CY, Li JB, Ren J, Chen MY, Liu LZ, Sun Y, Ma J. Du XJ, et al. Among authors: chen l, chen sy, chen yp, chen my, chen fp. Cancer Cell. 2024 Mar 11;42(3):464-473.e3. doi: 10.1016/j.ccell.2023.12.020. Epub 2024 Jan 18. Cancer Cell. 2024. PMID: 38242125 Free article.

2

Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: a retrospective study.

Huang CL, Fang XL, Mao YP, Guo R, Li WF, Xu SS, Ma J, Chen L, Tang LL. Huang CL, et al. Among authors: chen l. Cancer Cell Int. 2022 Oct 31;22(1):331. doi: 10.1186/s12935-022-02748-y. Cancer Cell Int. 2022. PMID: 36316696 Free PMC article.

3

Chemotherapy-Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA-Mediated PKR Activation.

Li Q, Zhao YH, Xu C, Liang YL, Zhao Y, He QM, Li JY, Chen KL, Qiao H, Liu N, Ma J, Chen L, Li YQ. Li Q, et al. Among authors: chen kl, chen l. Adv Sci (Weinh). 2023 Mar;10(8):e2205668. doi: 10.1002/advs.202205668. Epub 2023 Jan 22. Adv Sci (Weinh). 2023. PMID: 36683218 Free PMC article.

4

Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.

Mao YP, Wang SX, Gao TS, Zhang N, Liang XY, Xie FY, Zhang Y, Zhou GQ, Guo R, Luo WJ, Li YJ, Liang SQ, Lin L, Li WF, Liu X, Xu C, Chen YP, Lv JW, Huang SH, Liu LZ, Li JB, Tang LL, Chen L, Sun Y, Ma J. Mao YP, et al. Among authors: chen l, chen yp. BMJ. 2023 Feb 6;380:e072133. doi: 10.1136/bmj-2022-072133. BMJ. 2023. PMID: 36746459 Free PMC article. Clinical Trial.

5

Oral chemotherapy versus observation alone in nasopharyngeal carcinoma patients with persistently detected circulating cell-free Epstein-Barr virus DNA during follow-up.

Huang CL, Wang GY, Lou JH, Chen L, Li QJ, Li KP, Liang XY, Li YQ, Sun Y, Ma J, Guo R, Tang LL, Chen L. Huang CL, et al. Among authors: chen l. Radiother Oncol. 2024 Jan;190:110032. doi: 10.1016/j.radonc.2023.110032. Epub 2023 Nov 24. Radiother Oncol. 2024. PMID: 38007040

6

A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinoma.

Liang YL, Zhao YH, Ding C, Huang SW, Li Q, Zhu CM, He QM, Tang LL, Mao YP, Chen L, Li WF, Zhou GQ, Liu N, Jiang W, Ma J, Li YQ. Liang YL, et al. Among authors: chen l. iScience. 2023 Nov 14;26(12):108467. doi: 10.1016/j.isci.2023.108467. eCollection 2023 Dec 15. iScience. 2023. PMID: 38089590 Free PMC article.

7

RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ.

Tang H, Li X, Jiang L, Liu Z, Chen L, Chen J, Deng M, Zhou F, Zheng X, Liu Z. Tang H, et al. Among authors: chen j, chen l. Cancer Sci. 2022 Sep;113(9):3071-3084. doi: 10.1111/cas.15459. Epub 2022 Jun 28. Cancer Sci. 2022. PMID: 35701858 Free PMC article.

8

Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer.

Chen L, Liu Z, Tang H, Zhou Z, Chen J, Ma Z, Deng M, Li X, Wu Y, Zheng L, Zhou L, Zheng X, Liu Z. Chen L, et al. Among authors: chen j. Cell Prolif. 2022 Dec;55(12):e13325. doi: 10.1111/cpr.13325. Epub 2022 Aug 26. Cell Prolif. 2022. PMID: 36054300 Free PMC article.

9

Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial.

Wu D, Li Y, Xu P, Fang Q, Cao F, Lin H, Li Y, Su Y, Lu L, Chen L, Li Y, Zhao Z, Hong X, Li G, Tian Y, Sun J, Yan H, Fan Y, Zhang X, Li Z, Liu X. Wu D, et al. Among authors: chen l. Nat Commun. 2024 Mar 11;15(1):2177. doi: 10.1038/s41467-024-46444-z. Nat Commun. 2024. PMID: 38467604 Free PMC article. Clinical Trial.

10

Meroterpenoids from the marine-derived fungus Aspergillus terreus GZU-31-1 exerts anti-liver fibrosis effects by targeting the Nrf2 signaling in vitro.

Cui H, Tang Y, Yang C, Deng H, Chen L, Fan X, Zhu L, Liu Y, Zhao Z, Su T. Cui H, et al. Among authors: chen l. Phytochemistry. 2024 Mar;219:113983. doi: 10.1016/j.phytochem.2024.113983. Epub 2024 Jan 11. Phytochemistry. 2024. PMID: 38215814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,192 results

Search Page